The daily business briefing: September 30, 2020
Disney says it's laying off 28,000 workers, JPMorgan Chase agrees to $920 million market-manipulation settlement, and more
- 1. Disney laying off 28,000 employees as pandemic devastates theme parks
- 2. JPMorgan Chase agrees to $920 million market-manipulation settlement
- 3. Stock futures fall after contentious Trump-Biden debate
- 4. Moderna coronavirus vaccine shows promise in older adults
- 5. Boeing consolidates 787 Dreamliner production in South Carolina
1. Disney laying off 28,000 employees as pandemic devastates theme parks
Disney on Tuesday told employees it was going to have to lay off 28,000 employees across the entertainment giant's parks, experiences, and consumer products division. The cuts were necessary to offset losses at parks that have remained closed due to the coronavirus pandemic, and low attendance at parks that have reopened. About 67 percent of the employees being laid off were part-timers, Josh D'Amaro, head of parks at Disney, wrote in the letter. Disney's theme parks in Florida, Paris, Shanghai, Japan, and Hong Kong have reopened but with limited capacity, while both California Adventure and Disneyland in Anaheim, California, have remained closed. D'Amaro wrote in the letter that management had "worked tirelessly" to avoid layoffs, but cutting expenses and capital projects didn't save enough money.
2. JPMorgan Chase agrees to $920 million market-manipulation settlement
JPMorgan Chase & Co. agreed to pay $920 million to settle Justice Department market-manipulation investigations. The fine is the biggest the Commodity Futures Trading Commission and the Securities and Exchange Commission have ever imposed over a type of market manipulation called spoofing, in which people enter and quickly cancel large orders to deceive others about the supply and demand associated with a commodity or bond. Under the settlement, JPMorgan also will admit misconduct tied to manipulation of precious-metals and Treasury markets, the CFTC said. "The conduct of the individuals referenced in today's resolutions is unacceptable and they are no longer with the firm," said Daniel Pinto, co-president of JPMorgan Chase and CEO of the Corporate & Investment Bank.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
3. Stock futures fall after contentious Trump-Biden debate
U.S. stock index futures plunged early Wednesday after the chaotic first debate between President Trump and former Vice President Joe Biden. Futures for the Dow Jones Industrial Average, the S&P 500, and the Nasdaq were down by nearly 1 percent several hours before the opening bell. The candidates clashed over the economy, the Supreme Court, and Trump's handling of the coronavirus pandemic. Biden is leading in the polls, but Trump said he expected to do well, although he said the result might not be clear "for months" due to an expected surge in mail-in voting. "It was a long night and there's a lot that needs to be sorted out," said Daniel Deming, managing director at KKM Financial. "It became pretty apparent that this thing is not going to be over on Nov. 3 and I think the market is probably not too crazy about that."
4. Moderna coronavirus vaccine shows promise in older adults
Researchers said Tuesday that Moderna's coronavirus vaccine candidate produced virus-neutralizing antibodies in older adults that were similar to levels in younger adults. The study, published in the New England Journal of Medicine, also found that side effects from the vaccine were similar to those from high-dose flu shots. The side effects included headache, fatigue, body aches, and chills. "They might feel off or have a fever," said Dr. Evan Anderson, one of the study's lead researchers from Emory University in Atlanta. Anderson said the findings were reassuring, because immunity normally weakens with age. Moderna is testing the higher doses it researched in a large Phase III trial, the last hurdle before it can request emergency authorization or approval.
5. Boeing consolidates 787 Dreamliner production in South Carolina
Boeing this week is expected to firm up plans to concentrate its 787 Dreamliner assembly operations in South Carolina, The Wall Street Journal reported Tuesday, citing people familiar with the matter. The decision means the aircraft maker will end production of the jetliner in Washington state, a blow to the Seattle-area economy and Boeing's unionized workforce there. Boeing announced in July that it was looking into ways to respond to falling demand as the coronavirus pandemic reduces air travel. Earlier this year, Boeing said it was cutting production and trimming about 10 percent of its workforce.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.
-
Today's political cartoons - December 22, 2024
Cartoons Sunday's cartoons - the long and short of it, trigger finger, and more
By The Week US Published
-
5 hilariously spirited cartoons about the spirit of Christmas
Cartoons Artists take on excuses, pardons, and more
By The Week US Published
-
Inside the house of Assad
The Explainer Bashar al-Assad and his father, Hafez, ruled Syria for more than half a century but how did one family achieve and maintain power?
By The Week UK Published
-
Why Assad fell so fast
The Explainer The newly liberated Syria is in an incredibly precarious position, but it's too soon to succumb to defeatist gloom
By The Week UK Published
-
Romania's election rerun
The Explainer Shock result of presidential election has been annulled following allegations of Russian interference
By Sorcha Bradley, The Week UK Published
-
Russia's shadow war in Europe
Talking Point Steering clear of open conflict, Moscow is slowly ratcheting up the pressure on Nato rivals to see what it can get away with.
By The Week UK Published
-
Cutting cables: the war being waged under the sea
In the Spotlight Two undersea cables were cut in the Baltic sea, sparking concern for the global network
By The Week UK Published
-
The nuclear threat: is Vladimir Putin bluffing?
Talking Point Kremlin's newest ballistic missile has some worried for Nato nations
By The Week UK Published
-
Russia vows retaliation for Ukrainian missile strikes
Speed Read Ukraine's forces have been using U.S.-supplied, long-range ATCMS missiles to hit Russia
By Arion McNicoll, The Week UK Published
-
Has the Taliban banned women from speaking?
Today's Big Question 'Rambling' message about 'bizarre' restriction joins series of recent decrees that amount to silencing of Afghanistan's women
By Harriet Marsden, The Week UK Published
-
Cuba's energy crisis
The Explainer Already beset by a host of issues, the island nation is struggling with nationwide blackouts
By Rebekah Evans, The Week UK Published